Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

256 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
GH deficiency in adults: an epidemiological approach.
Sassolas G, Chazot FB, Jaquet P, Bachelot I, Chanson P, Rudelli CC, Tauber JP, Allannic H, Bringer J, Roudaut N, Rohmer V, Roger P, Latapie JL, Reville P, Leutenegger M. Sassolas G, et al. Among authors: jaquet p. Eur J Endocrinol. 1999 Dec;141(6):595-600. doi: 10.1530/eje.0.1410595. Eur J Endocrinol. 1999. PMID: 10601962
[Therapeutic strategies in somatotroph adenomas with extrasellar extension: role of the medical approach, a consensus study of the French Acromegaly Registry].
Jaquet P, Cortet-Rudelli Ch, Sassolas G, Morange-Ramos I, Chanson P, Brue T, Andrieu JM, Beckers A, Bertherat J, Borson-Chazot F, Brassier G, Caron P, Cogne M, Cottier JP, Delemer B, Dufour H, Enjalbert A, Figarella-Branger D, Gaillard R, Gueydan M, Jan M, Kuhn JM, Raingeard I, Regis J, Roger P, Rohmer V, Sadoul JL, Saveanu A, Tabarin A, Travers N, Trouillas J; French Acromegly Registry. Jaquet P, et al. Ann Endocrinol (Paris). 2003 Dec;64(6):434-41. Ann Endocrinol (Paris). 2003. PMID: 15067248 Review. French.
Resistance to somatostatin (SRIH) analog therapy in acromegaly. Re-evaluation of the correlation between the SRIH receptor status of the pituitary tumor and the in vivo inhibition of GH secretion in response to SRIH analog.
Bertherat J, Chanson P, Dewailly D, Enjalbert A, Jaquet P, Kordon C, Peillon F, Timsit J, Epelbaum J. Bertherat J, et al. Among authors: jaquet p. Horm Res. 1992;38(1-2):94-9. doi: 10.1159/000182500. Horm Res. 1992. PMID: 1306525 Review.
Consensus statement: medical management of acromegaly.
Melmed S, Casanueva F, Cavagnini F, Chanson P, Frohman LA, Gaillard R, Ghigo E, Ho K, Jaquet P, Kleinberg D, Lamberts S, Laws E, Lombardi G, Sheppard MC, Thorner M, Vance ML, Wass JA, Giustina A. Melmed S, et al. Among authors: jaquet p. Eur J Endocrinol. 2005 Dec;153(6):737-40. doi: 10.1530/eje.1.02036. Eur J Endocrinol. 2005. PMID: 16322377
Efficacy of chimeric molecules directed towards multiple somatostatin and dopamine receptors on inhibition of GH and prolactin secretion from GH-secreting pituitary adenomas classified as partially responsive to somatostatin analog therapy.
Jaquet P, Gunz G, Saveanu A, Dufour H, Taylor J, Dong J, Kim S, Moreau JP, Enjalbert A, Culler MD. Jaquet P, et al. Eur J Endocrinol. 2005 Jul;153(1):135-41. doi: 10.1530/eje.1.01950. Eur J Endocrinol. 2005. PMID: 15994755 Clinical Trial.
256 results